Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Covis Pharma (18 Drug Portfolio)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

18 drug portfolio of Covis Pharma. The portfolio includes branded pharmaceuticals, injectables and authorized generics that address life threatening and other serious medical conditions in various therapeutic areas including cardiovascular, central nervous system, oncology and acute care markets.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 1513 Walnut Street
  • Suite 270
  • Cary, NC 27511
  • United States

Covis Pharma (18 Drug Portfolio) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request full access to PitchBook

Covis Pharma (18 Drug Portfolio) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request full access to PitchBook